Pancreatic cystic tumors.

摘要: Cystic tumors of the pancreas are less frequent than other in neoplastic pancreatic pathology, but recent years literature has reported an increasing number. After first report by Becourt 1830, cystic were classified into 2 different types Compagno and Oertel 1978: benign with glycogen-rich cells mucinous neoplasms overt latent malignancy. The WHO classification exocrine pancreas, published 1996, is based on histopathological features epithelial wall, which main factor differential diagnosis lesions pancreas. Thanks to knowledge acquired up now, a surgical procedure not always required because therapeutic choice conditioned correct this heterogeneous group tumors. Clinical signs really useful clinical work up, most patients have no symptoms when present, they may help us pinpoint organ origin never identify type pathology. In last few years, great improvement imaging enabled only discriminate from solid lesions, also label them preoperatively. More invasive diagnostic procedures such as fine needle aspiration intracystic fluid tumor marker level sensitive wall can show degrees dysplasia de-epithelialization. These reasons for sending entire specimen Good cooperation between surgeons, pathologists, radiologists gastroenterologists mandatory increase chances making proper diagnosis. Therefore, we must analyze all information have, age, sex, history, location radiological features, order avoid mistake treating neoplasm lesion or pseudocyst, described literature. Except inoperable cases due critical condition patient non-resectable treatment differs therefore, tumors, real problem regarding inflammatory lesions. Even some perplexity remain about nature these value well playing role. role surgery central it could be curative complete resection possible. way, lack good results chemotherapy radiotherapy force surgeon go ahead procedure. Intraductal papillary represent new and, epidemiological point view, important chapter world margin aware that resection, total pancreatectomy sometimes required. approach changed thanks biological behavior fact, cases, now discussing possibility follow-up asymptomatic serous cystadenomas little branch side intraductal (IPMNs) patients. A planned even pseudopapillary seems risky leave untreated big young without certain so studies